Clinical Trials on Foot Ulcer, Diabetic in Argentina

Total 333 results

Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.

Diabetic Foot | Bacterial Infections | Osteomyelitis

China, Colombia, Estonia, Denmark, Taiwan, France, United States, Canada, Spain, Belgium, Austria, Chile, Korea, Republic of, Mexico, Slovakia, United Kingdom, Russian Federation, Croatia, Turkey, Lithuania, Poland, Latvia, Finland, H... and more
Ilkos Therapeutic Inc.

Completed

Dose-response Relationship Study of S42909 on Leg Ulcer Healing

Venous Leg Ulcer

Spain, Hungary, Canada, United States, Brazil, Argentina, Austria, Czechia, Italy, Poland, Slovakia
Hospital General de Niños Pedro de Elizalde

Completed

Flexible Catheter for Insulin in Diabetes

Diabetic Ketoacidosis

Argentina
School of Medicine. National University of Cuyo

Recruiting

Argentine Registry of Lp(a) (GAELpa)

Cardiovascular Diseases | Hypertension | Hypercholesterolemia | Diabete Type 2 | Lp(A)

Argentina
Actelion

Terminated

Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients (DUAL-2)

Digital Ulcers

Spain, United States, Argentina, China, Ireland, Colombia, Israel, New Zealand, Germany, Belgium, Portugal, Netherlands, South Africa, Greece, Mexico, Poland, Puerto Rico, Russian Federation, Turkey, Ukraine, United Kingdom
Hospital de Clinicas José de San Martín

Recruiting

Usefulness of Wireless pH Monitoring in GERD Diagnosis

Gastroesophageal Reflux

Argentina
Hospital Italiano de Buenos Aires
Universidad Nacional de La Plata; Instituto Tecnológico de Buenos Aires; Fundación...

Completed

Is the Artificial Pancreas, Without Carbohydrate Counting, Efficient and Safe in an Outpatient Setting

Type 1 Diabetes | Autoimmune Diabetes

Argentina
Sanofi

Terminated

Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2) (Malbec)

Type 2 Diabetes

Argentina
Hospital Italiano de Buenos Aires

Completed

Healthy Habits Program for High Cardiovascular Risk Patients: Randomized Controlled Clinical Trial

Motor Activity | Health Behavior | Food Habits

Argentina
GI Windows, Inc.

Active, not recruiting

Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes

Obesity | Type 2 Diabetes

Argentina
Diatranz Otsuka Limited

Completed

Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes

Argentina
Novo Nordisk A/S

Completed

Human Insulin NPH and Insulin Aspart in Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Argentina
Hospital Italiano de Buenos Aires

Completed

Hemoglobin A1c and Immediate Postsurgical Complications Diabetes Type 2 (HbA1c)

Postoperative Complications

Argentina
Centro de Endocrinologia Experimental y Aplicada
National Council of Scientific and Technical Research, Argentina

Completed

Educative Intervention to Improve Type 2 Diabetes Mellitus Control in Corrientes (PRODIACOR)

Type 2 Diabetes

Argentina
Center for Pharmacological and Botanical Research
Sociedad Argentina de Diabetes

Recruiting

Effect of Extra Virgin Olive Oil Addition in the Diet of Women With Gestational Diabetes Mellitus (OLIDIAG) (OLIDIAG)

Gestational Diabetes

Argentina
Hospital General Puyo

Unknown

Hb A1C Pre and Post Confinement in Latin American Children With Type 1 Diabetes: Dulce Study Group

Type1diabetes | Childhood ALL

Argentina
Living Cell Technologies

Completed

Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes

Argentina
Hospital Italiano de Buenos Aires

Completed

Effectiveness of a High-risk Diabetic Patients Program

Diabetes Mellitus, Type 2

Argentina
Novartis Pharmaceuticals

Completed

Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy

Diabetic Nephropathy

Czechia, Lebanon, United States, Argentina, Germany, Jordan, Turkey
Ministry of Public Health, Argentina
Aix Marseille Université; Instituto de Biología y Medicina Experimental, IBYME...

Unknown

Effect of Linagliptin on TRL Metabolism

Type 2 Diabetes

Argentina
Fundacion GESICA

Completed

Aspirin Statins Or Both For The Reduction Of Thrombin Generation In Diabetic People (RATIONAL)

Diabetes Mellitus

Argentina
AstraZeneca

Completed

Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA) (Oberon)

Gastric Ulcer | Duodenal Ulcer

United States, Bulgaria, Czech Republic, Korea, Republic of, Russian Federation, South Africa, Philippines, Poland, Romania, Finland, Norway, Canada, Mexico, Argentina, Australia, Germany, Portugal, Slovakia, Thailand, Indonesia
AstraZeneca
Bristol-Myers Squibb

Completed

Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects

Diabetes Mellitus, Type 2

Argentina
National Council of Scientific and Technical Research...
Illumina, Inc.; Facultad de Ingeniería - Universidad Austral; Instituto de Inmunología... and other collaborators

Recruiting

Microbiome and Health Indicators in People With Obesity, Prediabetes and Type 2 Diabetes Undergoing a Lifestyle Intervention (MicrobiAr)

Obesity | Diabetes Mellitus, Type 2 | PreDiabetes

Argentina
Hospital General de Niños Pedro de Elizalde

Terminated

Two Bag System for Hydration in Diabetes

Diabetes | Ketoacidosis

Argentina
Novo Nordisk A/S

Completed

Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Argentina, Brazil
The Foundation for Orthopaedics and Regenerative...

Recruiting

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Eye Diseases

Glaucoma | Eye Diseases | Macular Degeneration | Diabetic Retinopathy | Retinitis Pigmentosa | Optic Atrophy | Traumatic Optic Neuropathy

Antigua and Barbuda, Argentina, Mexico
GlaxoSmithKline

Terminated

An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II Diabetes

Diabetes Mellitus, Type 2

Argentina
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)

Diabetic Neuropathy, Painful

Turkey, Colombia, Taiwan, Jordan, Lebanon, United Arab Emirates, Ecuador, Argentina, Korea, Republic of, Mexico, Brazil, Chile, Indonesia, Malaysia, Philippines, Saudi Arabia, Singapore, Thailand, Venezuela
Especialistas en Retina Medica y Quirurgica Grupo...
Centro de Retina Medica y Quirurgica S.C.

Completed

MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2) (MINIMA-2)

Diabetic Macular Edema

Argentina, Mexico
Austral University, Argentina

Recruiting

Cardiometabolic Risk Factors Registry (CARFARE)

Cardiovascular Diseases | Obesity | Diabetes | Atherosclerosis | Metabolic Syndrome | Cardiovascular Risk Factor

Argentina
GlaxoSmithKline

Completed

A Study To Assess The Safety And Tolerability Of GSK189075 When Given With A Total Daily Dose Of >/ 2000mg of Metformin

Diabetes Mellitus, Type 2

Argentina, Germany, United States
Novartis Pharmaceuticals

Active, not recruiting

Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy (CONDOR)

Proliferative Diabetic Retinopathy

China, India, Japan, Russian Federation, Turkey, Canada, United States, Australia, Korea, Republic of, Brazil, Philippines, Puerto Rico, Taiwan, Argentina, Chile, Mexico
Bayer

Completed

A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR) (ReFineDR)

Diabetic Retinopathy

Korea, Republic of, Russian Federation, Hong Kong, Taiwan, United States, Argentina, Japan, Denmark, Israel, Spain, Sweden, China, Colombia, Italy, Portugal
The Foundation for Orthopaedics and Regenerative...

Recruiting

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Diabetes

Diabetes

Antigua and Barbuda, Argentina, Mexico
AstraZeneca

Completed

A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI) (NEON)

Gastroesophageal Reflux Disease

Chile, Argentina, Venezuela, Colombia
Sanofi

Completed

Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients (SERENADE)

Type 2 Diabetes Mellitus

United States, Poland, Germany, Netherlands, Argentina, Hungary, Chile
Pfizer

Completed

A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy

Diabetic Nephropathy

United States, Spain, Korea, Republic of, Australia, Hong Kong, Germany, Poland, Italy, Canada, Puerto Rico, Malaysia, Romania, Argentina, Peru
Sanofi

Completed

Safety and Effectiveness Study of Insulin Glargine (LANTUS) Initiation and Titration in Patients With Type 2 Diabetes (AFICIONADO)

Diabetes Mellitus, Type 2

Argentina
Bayer

Completed

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease (FIGARO-DKD)

Diabetic Kidney Disease

Belgium, Finland, France, Spain, China, Hong Kong, Switzerland, United States, Colombia, Turkey, Greece, New Zealand, Poland, Korea, Republic of, Portugal, Taiwan, Japan, Russian Federation, Singapore, Australia, Netherlands, Sweden, Austr... and more
Sanofi

Completed

Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin (ARTEMIS-DM)

Type 2 Diabetes Mellitus

Argentina, Colombia, Egypt, Hong Kong, India, Indonesia, Lebanon, Malaysia, Peru, Philippines, Saudi Arabia, South Africa, Thailand, Turkey
Sanofi

Completed

Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study (NICE)

Ulcerative Colitis | Inflammatory Bowel Disease

Canada, Brazil, Russian Federation, Italy, Spain, Sweden, Estonia, Singapore, Belgium, Czech Republic, Argentina, Hungary, Chile, South Africa
Boehringer Ingelheim

Completed

A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease

Diabetic Nephropathies

Spain, Australia, United States, Canada, China, Japan, Malaysia, United Kingdom, Mexico, Portugal, Denmark, Hong Kong, Poland, New Zealand, Argentina, Netherlands
Janssen Research & Development, LLC
The George Institute for Global Health, Australia

Completed

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (CREDENCE)

Diabetes Mellitus, Type 2 | Diabetic Nephropathy

United States, Canada, France, Germany, Poland, Ukraine, United Kingdom, China, Taiwan, Spain, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Serbia, South Africa, Japan, Australia, Korea, Republic of, Chile, New Zealand and more
AstraZeneca

Completed

A Phase 2b Diabetic Kidney Disease Study

Diabetic Kidney Disease

United States, Chile, Korea, Republic of, Japan, Argentina, Canada, Peru
Sanofi

Completed

Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment

Type 2 Diabetes Mellitus

France, Poland, Germany, Italy, Netherlands, Belgium, Denmark, Chile, South Africa, Australia, Argentina
Boehringer Ingelheim

Completed

A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)

Hypertension | Diabetic Nephropathies

Taiwan, United States, Canada, Thailand, Korea, Republic of, Argentina, Australia, Brazil, Mexico, New Zealand
Amgen

Recruiting

Long-term Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis

United States, Germany, Japan, Denmark, Romania, Argentina, Bulgaria, Hungary, Korea, Republic of, Mexico, Poland, Switzerland, Turkey
Eli Lilly and Company
Alkermes, Inc.

Completed

Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP) (IDAP)

Diabetes Mellitus, Type 2

United States, Argentina, Portugal, South Africa
Sanofi

Completed

Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO)

Type 2 Diabetes Mellitus

France, Russian Federation, United States, Argentina, Canada, Germany, South Africa, Italy, Netherlands, United Kingdom, Australia, Chile

Clinical Trials on Foot Ulcer, Diabetic in Argentina

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations